Abiopharma

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia

InvenTrust Properties Corp. Announces Second Quarter 2026 Earnings Release and Conference Call Dates

Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)

Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®

Uranium Royalty Corp. Announces Filing and Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders to Approve Proposed Plan of Arrangement with Sweetwater Investors and Announces Exchangeable Share Election Deadline

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of DSC Holdings Ltd.

Amerant Bancorp Inc. to Announce Second Quarter 2026 Financial Results and Host Conference Call

AES Stockholders Approve Acquisition by Global Infrastructure Partners and EQT-Led Consortium

Stack Capital Group Inc. Announces Results of Its 2026 Annual General Meeting & Election of Directors

DAYBU® (trofinetyd) zalecany w UE przez CHMP do stosowania w leczeniu zespołu Retta